In this paper, a large-scale multicentre patient dose study performed in eight Belgian interventional cardiology departments is presented. Effective dose (E) was calculated based on a detailed dose-area product (DAP)-registration during each procedure and by using conversion coefficients generated by the Monte Carlo-based computer program PCXMC. Conversion coefficients were found to be 0.177 mSv Gycm 22 for systems that do not use any additional copper filtration in cineradiography and 0.207 mSv Gycm 22 for systems that use additional copper filtration in cineradiography. Mean E values of 9.6 and 15.3 mSv for diagnostic and therapeutic procedures, respectively, were obtained. DAP distributions were investigated in order to derive dose reference levels: 71 and 106 Gycm 2 for diagnostic and therapeutic procedures, respectively, are proposed. Significant differences were observed in DAP distributions taking into account whether additional copper filtration was used in the cineradiography mode. Apart from the skin, the organs most at risk are lungs and heart. The probability of fatal cancer for the studied population amounted to 1.1 3 10 24 and 2.1 3 10 24 for diagnostic and therapeutic procedures, respectively, for the age distribution of the patients considered in this multicentre study.
INTRODUCTION
Effective dose (E), introduced by the International Commission on Radiological Protection (ICRP) in Publication 60 (1) , represents the risk of late radiationinduced effects such as malignancies and genetic effects.
During cardiac procedures in the catheterisation laboratory carried out under fluoroscopic control, such as coronary angiography (CA) and percutaneous transluminal coronary angioplasty (PTCA), the radiation doses received by the patient can be high (2 -5) . The hazards associated by the use of X rays must therefore be justified by the procedure's benefits. Adaptation of the clinical protocols and knowledge of E or other dose-related quantities such as dose -area product (DAP) of a procedure can lead to optimisation of patient safety and image quality in fluoroscopically guided invasive cardiovascular procedures (6) . In order to determine E for a certain X-ray examination, knowledge of specific organ doses is essential. Unfortunately, specific organ doses cannot be measured directly during the procedure. Therefore, Monte Carlo-based computer simulation codes are available, providing organ doses as a function of DAP or entrance surface dose (ESD) for certain irradiation geometries, X-ray spectra and clinical examination parameters. Thus, the problem of determination of organ doses in order to find the effective dose has shifted towards the calculation of accurate DAP to E conversion factors.
The National Radiological Protection Board (NRPB) has published conversion factors for E, referring to both DAP and ESD measurements for 68 common radiographic projections and 9 complete X-ray examinations (7) . Tapiovaara et al. (8) , of the Finnish Centre for Radiation and Nuclear Safety (STUK), developed a Monte Carlo-based computer program PCXMC in order to define specific E conversion factors in freely adjustable X-ray projections and other examination conditions used in projection radiography and fluoroscopy.
For a number of types of interventional procedures used in cardiology, conversion coefficients can be found in the literature. Reported values are mainly restricted to a total conversion coefficient for E owing to a complete procedure. For instance, PTCA values of 0.18 (9) and 0.27 mSv Gycm 22 (10) were reported for conversion of DAP to E. This study was undertaken in catheterisation rooms in eight different Belgian hospitals, covering 318 patients of which 200 underwent a diagnostic procedure and 118 underwent a therapeutic procedure. Equivalent organ doses and effective dose were calculated based on DAP values recorded during the whole procedure. The goal of this study is to determine DAP/E conversion coefficients using the Monte Carlo code PCXMC and the information gathered in the catheterisation rooms. Dependency of conversion factors of additional copper (Cu) filtration used in cineradiography was examined. DAP distributions were interpreted in terms of dose reference levels (DRLs), and mean values of each hospital specific distribution were compared with the proposed DRLs.
MATERIALS AND METHODS

Population and interventional procedures
E was calculated for a total number of 318 patients (221 male, 97 female, age between 29 and 89) who underwent cardiac catheterisation over a period of 2 y (July 2003-July 2005) in eight hospitals in Belgium, selected to be representative for the whole territory. Mean BMI was found to be 27.5 kg m 22 , ranging from 19 to 49 kg m
22
. In each hospital, about 40 patients in one catheterisation room were included. Patients were asked to keep their arms behind their neck during the procedure.
The cardiac interventional procedures were divided into two groups. The first group comprises diagnostic CA possibly combined with pulmonary capillary wedge pressure measurements. The second group consists of therapeutic procedures: single or multiple PTCA with or without single or multiple consecutive stenting, single or plural direct stenting and combined (diagnostic plus therapeutic) procedures. The procedures were performed by experienced cardiologists or medical doctors being in training for interventional cardiology. A total of 200 diagnostic and 118 therapeutic procedures were included in this study.
X-ray equipment and DAP-meters
The measurements were performed on different contemporary cardiac X-ray systems. Table 1 gives detailed information about the systems and describes the possible filtration combinations used in fluoroscopy and cineradiography mode.
Most frequently, a combination of an aluminium (Al) filtration of a particular thickness and one or more Cu filters of different thickness is used in addition to an inherent filtration of 2.5 mm Al. If one looks into detail at the filtration for the two modes, it can be seen, as indicated in Table 1 , that systems 2, 5, 7 and 8 have additional Cu filtration available for cineradiography mode and that for systems 1, 3, 4 and 6 this is not the case. For the fluoroscopy mode, all systems have the possibility to use extra Cu filtration. All X-ray tubes were operated in a pulsed mode and controlled tube voltage and anode current with automatic brightness control. 
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As calculation of E was based on the DAP values of the different projections used in the procedure, all X-ray tubes are equipped with a DAP meter. These DAP meters (PTW, Freiburg) were all integrated in the system and were calibrated in situ for different tube voltages, filtrations and modes (fluoroscopy or cineradiography) with a 60-cc ionisation chamber (Radcal, 10X5-60, Dutoit Medical) and 33 Â 41-cm Kodak X-Omat V films (Eastman Kodak) for field size determination.
Image quality was checked for all systems, at normal clinical conditions using a Leeds FG18 phantom to comply with the minimum criteria, defined in Radiation Protection 91 Report of the European Commission (RP91) (11) . According to this report, the contrast threshold under automatic brightness control should be 4%. With respect to the resolution, the requirements to be met for field sizes of [23] [24] [25] (12) . After each intervention, the following information was also recorded: complexity of the intervention (score 1 to 3), cardiologist's experience (doctor or trainee) and patient's data (gender, age, weight and length).
Calculation of equivalent organ doses and effective dose
Using the recorded data, equivalent organ doses and E were calculated. Values for E were derived using two different methods for determination of conversion coefficients (mSv Gycm
22
), converting DAP into E. The first method used the Monte Carlobased computer simulation program PCXMC, developed at the Medical Radiation Laboratory of the Finnish Radiation and Nuclear Safety Authority (8) . The user defines, via a graphical interface, beam parameters such as focus to skin distance, rotation geometry in transverse and sagittal plane, skin entry point and field size at this position. According to the practical set-up of this study, the arms were left out of the hermaphrodite phantom of the program.
The second method used the tables of conversion factors, published by the NRPB (7) . These factors were derived for certain filtrations and irradiation geometries for radiological examinations of different organs. The calculation of the coefficients in the NRPB report was based on the Monte Carlo technique, as described by Jones and Wall (13) . Specific factors for examinations of the heart are listed for four specific irradiation geometries.
The calculation of E with PCXMC was practically performed taking into account a set of standard projections describing the irradiation geometry. These standard projections are adapted to the local clinical protocol used for diagnostic procedures and are specific for each hospital. For therapeutic procedures, the cardiologist selects a projection used in the diagnostic procedure where the lesion is most clearly visible. As a consequence, the standard projections used for diagnostic procedures can also be used to describe the geometry for therapeutic procedures. Practically, each standard projection can be characterised by two angles (u and w). Each projection in the cardiac intervention of a patient was decoded in the same way by u 0 and w
0
. A study of the differences between u and u 0 and between w and w 0 allowed to determine the standard projection closest to each patients projection. The data on the geometry for the standard protocols of each hospital are summarised in Table 2 . These standard projections include geometries for frontal and lateral tubes in the case of biplane systems.
Contrary to cineradiography where the projections are fixed during imaging, fluoroscopy implies rotation of the tube, resulting in multiple projections for guidance of the catheter. However, a very logical assumption about the irradiation geometry for fluoroscopy can be made taking into account the fact that fluoroscopy always precedes cineradiography in order to have the optimal view of the heart and the catheter during the following cineradiography run. Therefore, the different fluoroscopy projections were reduced to one covering projection chosen to be the same as that used in the following cineradiography run.
Beside irradiation geometry represented in the standard projections, other parameters such as field size, filtration and tube voltage, specific for a hospital's equipment and/or clinical protocol have to be taken into account. The source to image receptor distance (SID) was kept systematically 98 cm for monoplane systems and 105 cm for biplane systems with a distance from patient's skin to image intensifier of 10 cm. For projections with an angle in the cranial direction that was larger than or equal to 408, the SID was increased with 5 cm and the distance from patient's skin to image intensifier with 10 cm. It is necessary to simulate the real clinical situation for this kind of projections.
Factors were calculated for the three different image receptor field sizes possible for each hospital (e.g. 23, 17 and 13 cm), and the different filtrations used in each hospital were taken into account.
For a certain standard projection with appropriate geometry, field size and filtration, conversion factors were calculated using PCXMC for tube voltages between 50 and 120 kV in steps of 10 kV. This implied calculation of a total of 5328 conversion factors. For tube voltages in-between, interpolation of the conversion factors was applied. Figure 1 gives an example of the kilovoltage dependence of the DAP to E conversion factors for a standard projection of hospital 1 characterised by LAO 10 CRAN 10 and a field size of 17 cm. DAP values of the individual patients were used together with the conversion factors calculated for an adult hermaphrodite phantom with reference dimensions, which is essentially based on the phantom of Cristy (14) . As the program only allows a scaling in the height and weight of the phantom Monopl., monoplane system; bipl., biplane system.
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including its organs, without adding any additional layers of adipose tissue, it would lead to a simulation that is not realistic. As a consequence, the dimensions of the individual patients were not used as input in the program. Moreover, as a very large number of patients was considered in this study (318), the average dimensions of the patient group approached the reference dimensions. Therefore, no size correction (15) was applied. Summarising, calculation of effective dose for each patient using PCXMC implies multiplication of the correct conversion factor defined by field size, filtration, tube potential and geometry with the DAP contribution for each consecutive mode (fluoroscopy and cineradiography) in the procedure of that patient. This results in an effective dose contribution for each projection used in the cardiac intervention. Summing these effective dose contributions gives the effective dose for a specific patient.
Although, for the procedure of dose calculation with PCXMC, a set of standard projections was derived from the clinical protocol for each hospital, only four standard projections are available in the NRPB tables, implying a reduction of the number of conversion coefficients. The coefficients are given for spectra with peak potential ranging from 50 to 120 kV and total beam filtrations of 2 to 5 mm Al. Cu is not considered as filtration material in the tables. For the dose calculations based on the NRPB tables, each projection during a catheterisation procedure of a patient is reduced to one of the four available standard projections. The same method for assessment of the fluoroscopy projection as explained for E calculation with PCXMC is applied here. Interpolation is performed for tube voltages when necessary.
Recent X-ray tubes for interventional cardiology are equipped with Al and Cu filtration, while the NRPB tables only consider Al filtration. In case of the procedures with Cu filtration, the maximum value of Al filtration of the tables, 5 mm, is used. The standard focus-to-skin distance (FSD) applied in the NRPB tables is 45 cm. Calculated from the SID, the FSD used for the PCXMC calculations ranged from 63 to 75 cm, taking into account projections with angulations larger than or equal to CRAN 40.
Equivalent organ doses were calculated using PCXMC. The simulation resulted in conversion factors for DAP to equivalent dose (mSv Gycm 22 ) for different organs together with the DAP to E conversion factors for the different standard projections, field-size, filtration and tube voltage, as described above. Equivalent organ doses were considered for diagnostic and therapeutic procedures separately.
Effect of patient support table
The effect of the patient support table being in the beam at frontal projections had to be considered when calculating the effective dose, both with the PCXMC program and NRPB tables. Patient support table induces beam hardening but influences to a greater extent the photon fluence in the beam. Beam hardening implies an increase in the effective dose contribution for frontal projections, whereas a decrease of photon fluence implies a decrease in effective dose contributions. Both effects will only partially compensate, resulting in a decrease in the effective dose contribution for frontal projections. Beam-hardening effect was simulated by PCXMC and the decrease in fluence, due to presence of patient support table, was measured. We found all patient support tables, except for the patient support table in hospital 7, to have an equivalent of 0.8 mm Al, which caused an increase of effective dose contribution for frontal projections of 11.5%. The patient support table of hospital 7 had an equivalent of 0.5 mm Al, causing an increase of 7.4% in the effective dose contribution for frontal projections. Decrease in photon fluence was measured to be 32.6% for all hospitals except for hospital 7 where the decrease in photon fluence was 19.4%. The resulting factor for the decrease of effective dose contribution for projections with patient support table in the beam was 0.751 for all hospitals, except for hospital 7 where the factor was 0.866. For all frontal and inclined projections for which the patient support table was located in the beam, these factors were applied.
Statistical analysis
Because multiple factors may influence radiation dose measurements and calculations, a multifactor analysis of variance (ANOVA) was set up. Factors in the ANOVA design included the differences between hospitals, the difficulty of the procedure, system of beam filtration insertion and type of equipment (bi-/monoplane, digital flat panel or conventional image intensifier). Levene's test was used to test the homogeneity of the variances between groups. A non-significant result of the Levene's test assured a correct application of the ANOVA analysis. Pillai's trace was used as a robust indicator of significance in the ANOVA analysis (16) . In cases where only two groups had to be compared, a non-parametric two-tailed Mann-Whitney test was performed. Correlations between groups were calculated by means of the non-parametric Spearman's rank correlation coefficient (r). To calculate the regression coefficients in the relation between two quantities, linear regression analysis was performed using the Levenberg-Marquardt algorithm. The difference between regression lines was calculated using the general linear model.
In all statistical calculations, a confidence interval of 95% was applied. Hence, a p-value ,0.05 was considered as significant. All calculations were performed by means of the SPSS 12.0 software (SPSS, Chicago, IL, USA).
RESULTS
Mean values of DAP and E for diagnostic and therapeutic interventions in the different hospitals of this study are listed in Table 3 Figure 6 shows the correlation between total DAP values and calculated E. An excellent overall correlation between the effective dose and DAP was found, resulting in a conversion factor of 0.185 mSv 
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for other systems. The p-value for the distinction of the slope of both regression lines was smaller than 0.001. Relative contributions of fluoroscopy and cineradiography to E were calculated. Fluoroscopy contributions for both diagnostic and therapeutic procedures are represented in Figure 7 . Mean values were 39% for diagnostic and 56% for therapeutic procedures. Of all hospitals, hospital 6 has a very large contribution of fluoroscopy to E for both types of procedures. This is due to the continuous use of 
high fluoroscopy mode, with the lowest filtration in the X-ray beam in this hospital. Besides the use of the Monte Carlo simulation program PCXMC, E was also calculated using the NRPB tables and the measured DAP values. E calculated based on the NRPB tables is, in general, 12% lower.
Equivalent doses for all organs defined in ICRP 60 (1) were calculated with PCXMC. Organs that received the highest dose are listed in Table 4 . As expected, the lungs and the heart were exposed to the highest level and receive mean equivalent doses in the range of 40 and 60 mSv for diagnostic and therapeutic procedures, respectively. Doses for liver, breasts, pancreas and muscle were calculated to be below 15 mSv for both diagnostic and therapeutic procedures. Stomach, thyroid, kidneys, spleen and gall bladder received doses lower than 5 mSv while ovaries, testes, intestine, urinary bladder, brain and uterus receive a low dose level (,0.5 mSv).
Imaging performance tests were carried out for all X-ray systems and were checked to comply with RP91 (11) . Concerning contrast visibility, all systems fulfilled the criteria (contrast threshold under automatic brightness control 4%). Average values for contrast threshold at normal operation mode were 2.4% (10% variation in terms of percentage) for fluoroscopy and 1.5% (8% variation in terms of percentage) for cineradiography. This difference is statistically significant ( p , 0.001). With respect to the resolution, all systems except for two fulfilled the requirements of RP 91 (for field sizes of 23-25 cm, resolution should be at least 1.0 lp mm 21 , and for field sizes of 15 -18 cm, at least 1.4 lp mm
21
). The elder image intensifiers of hospitals 3 and 6 did not comply with the criteria for magnification (smallest fields). Average values for resolution for fluoroscopy and cineradiography at normal operation mode were 2.00 lp mm 21 (18% variation in terms of percentage) and 2.16 lp mm 21 (18% variation in terms of percentage), respectively. This difference is not significant ( p ¼ 0.236).
DISCUSSION AND CONCLUSION
In this study, detailed DAP registration made determination of overall DAP distributions possible. Third quartile values led to national DRLs for interventional cardiovascular diagnostic and therapeutic procedures. The proposed values are 71 and 106 Gycm 2 for diagnostic and therapeutic procedures, respectively. These correlate well with DRLs proposed in Refs. (17) and (18) (19) for cardiac catheterisation, stent insertion and PTCA, respectively, in a national survey in Switzerland. They attribute the large difference with the literature in DRL for diagnostic procedures (CA) to the variability in techniques used, particularly in the case of complex examinations. The lower values found by Aroua et al. for stent insertion and PTCA in comparison with the present work can be explained by the fact that 'therapeutic' procedures, as defined in this study, also contain combined procedures where a therapeutic intervention immediately follows a diagnostic examination.
Figures 2 and 3 show a significant difference in DAP distribution depending on the availability of additional Cu filtration. Lower DAP values can be attributed at least partly to higher filtration of the X-ray equipment in cineradiography mode and might be lowered even more by dose conscious action or training of the cardiologists. The data support that additional Cu filtration is a very helpful tool for dose reduction if correctly installed or upgraded and implemented in clinical practice. Dose saving tools such as additional Cu filtration can be implemented on an existing X-ray system to lower mean values of a local distribution, in order to comply with established DRLs. Additional filtration will lower not only DAP values but also skin doses and E.
A good correlation was found between E and DAP, providing an overall conversion factor between these two quantities of 0.185 mSv Gycm 22 (Table 5) . Statistical significance was not observed for the difference in DAP/E conversion factors between diagnostic and therapeutic procedures.
However, distinction based on filtration used in cineradiography mode in terms of the availability of extra Cu material in the beam does make sense. A conversion factor of 0.207 mSv Gycm 22 for systems that use extra Cu filtration in cineradiography was found, whereas the conversion factor amounts to 0.177 mSv Gycm 22 for the other systems. The beam hardening as a consequence of the additional Cu filtration leads to a higher mean E-value for the same DAP value.
Although conversion factors were calculated for each hospital individually, taking into account the X-ray set-up and the clinical protocol, as stated by Schultz and Zoetelief (20) , geometry related factors did not result in significant differences in conversion factor. The standard projections derived from the clinical protocol and presented in Table 2 show that more geometries are used in biplane than in monoplane systems and that different hospitals indeed use different projections. The lateral projection LAO 90 CAUD 0, for instance, is not included in the standard clinical protocol of hospital 7. Instead of influencing E, this fact affects mostly maximum skin dose, as highest values for this dose quantity can be found under this projection, as shown in a complementary study in the same eight hospitals (21) . Considering the different standard projections of the hospitals, we see that only hospitals 3, 4 and 6 use the pure frontal (AP) projection (LAO 0 CAUD 0) to make a cineradiography run, whereas the other hospitals use this projection only during fluoroscopy at the beginning of the procedure for guidance of the catheter.
Effective doses were calculated for 318 cardiovascular procedures taking into account the X-ray setup and the clinical protocol in each participating hospital using the Monte Carlo Code PCXMC and also using conversion coefficients of the NRPB tables. As a result of the PCXMC calculations, a mean value of 9.6 mSv was obtained for the effective dose of diagnostic procedures but with individual outliers up to 60.7 mSv. The UNSCEAR 2000 report indicates as mean value for health care level I countries 7.3 mSv. With this effective dose, CA is among the medical applications of diagnostic X rays with a high patient radiation burden. Computed tomography of the thorax and the abdomen induced similar doses of 9.7 and 12.0 mSv, respectively (22) . For patients undergoing therapeutic interventions, the mean effective dose of this study was 15.3 mSv with outliers up to 79.8 mSv. For comparison, the mean effective dose for a PTCA intervention reported in the UNSCEAR 2000 report was 22 mSv. In the study by Neofotistou et al. (23) , individual patient data ranged from 7.5 up to 57 mSv. Dose values of 5.6 mSv for diagnostic procedures and of 13.0 mSv for therapeutic procedures were reported by Betsou et al. (9) . Dose ranges of 4.6-15.8 (23) and 2.7-8.8 mSv (24) for diagnostic procedures and of 5.4-41.0 (23) and 5.7 -15.3 mSv (24) for therapeutic procedures were reported before. Both dose values and dose ranges present slightly lower mean E values than observed in this study. It should be mentioned that Betsou et al. (9) based E determination on phantom (RANDO) measurements, Neofotistou et al. (23) based their E determination on effective dose conversion factors published by NRPB and only Stisova (24) based E determination on PCXMC calculations.
In this study, comparing the E determined using the NRPB tables with E calculated by means of PCXMC revealed a systematically lower value (12%). This can be explained by the fact that NRPB only provides conversion factors for beam filtration in millimetres of Al, which cannot always be applied in contemporary equipment for interventional cardiology. Cu filters are often inserted into the beam as skin-dose saving tool. A higher filtration implies beam hardening and thus a higher E value to be expected.
When one looks at the organs at risk, certainly the skin is the most important tissue. However, in contrast with maximal skin dose, mean skin doses are of no interest. The skin is only partially exposed and only hot spots of high doses can relatively easy pass the threshold for deterministic effects: 2 Gy (1) . With respect to the skin, PCXMC is able only to calculate mean doses. If one wants to know what the maximal skin doses amounts to, one should perform in situ measurements using thermoluminescent dosimeters. This was performed in a complementary study in the same eight hospitals (21) . Organs directly in the beam apart from the skin that receive highest equivalent dose are the lungs and the heart.
The risk for late effects is strongly dependent on patient's age and is different for males and females. In Figure 8 , the age dependence of the attributable lifetime risk in per cent per Sievert according to the ICRP Publication 60 (1) following the multiplicative model is depicted graphically for males and females. On the same figure, the age distribution of the patients considered in this multicentre study is presented. Using these data together with the effective doses of the patient population, the average risk for late effects for a diagnostic cardiologic intervention amounts to 1.1 Â 10 24 for both males and females and 2.1 Â 10 24 for a therapeutic cardiologic intervention also for both genders, for the age distribution of the patients considered in this multicentre study. In view of these values, all measures have to be taken to reduce the cumulative DAP value and consequently also the effective dose leading to a reduced risk for late effects, especially when treating relatively young patients.
In conclusion, from this study national DRLs for Belgium for diagnostic and therapeutic cardiovascular interventional procedures could be derived for DAP values. Proposed conversion factors for E differed significantly for systems that used additional Cu filtration in cineradiography mode and systems that did not.
Additional Cu filtration is a very effective dose saving the tool on X-ray systems used for fluoroscopy-guided procedures and has its influence on the dose registered to the patient through lower DAP and E values. Therefore, comparison of local mean values with DRLs, together with specific practical training for cardiologists leading towards dose conscious action and towards practical use of dose saving tools in X-ray equipment, make dose reduction possible. Figure 8 . Age distribution of the patients included in this study and age dependency of the lifetime risk for males and females in per cent per Sievert (1) .
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